Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
China flag China · Delayed Price · Currency is CNY
57.53
-0.59 (-1.02%)
At close: Mar 9, 2026

Hangzhou AGS MedTech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
293.39217.24144.96104.8
Depreciation & Amortization
8.856.566.264.4
Other Amortization
1.21.141.441.96
Loss (Gain) From Sale of Assets
0.190.350.140.01
Asset Writedown & Restructuring Costs
0.020.461.961.01
Loss (Gain) From Sale of Investments
-21.63-2.117.19-1.72
Provision & Write-off of Bad Debts
-0.52.15--
Other Operating Activities
1.461.81-11.534.73
Change in Accounts Receivable
9.42-39.77-8.190.08
Change in Inventory
-13.61-12.67-1.28-22.19
Change in Accounts Payable
32.4445.4415.725.06
Change in Other Net Operating Assets
3.912.4--
Operating Cash Flow
315.8221.45156.38118.25
Operating Cash Flow Growth
42.60%41.61%32.24%121.61%
Capital Expenditures
-49.6-51.57-60.12-15.66
Sale of Property, Plant & Equipment
0.040.080.030
Investment in Securities
-1,081-25.3-55-
Other Investing Activities
---3.510.37
Investing Cash Flow
-1,130-76.79-118.6-15.29
Long-Term Debt Repaid
-0.85-1.18-1.52-0.67
Total Debt Repaid
-0.85-1.18-1.52-0.67
Net Debt Issued (Repaid)
-0.85-1.18-1.52-0.67
Issuance of Common Stock
5.871,820--
Repurchase of Common Stock
-30.97---
Common Dividends Paid
-83.33-43.98-35.95-49.05
Other Financing Activities
--177.6-1.15-
Financing Cash Flow
-109.281,598-38.62-49.72
Foreign Exchange Rate Adjustments
0.320.659.45-4.75
Net Cash Flow
-923.511,7438.6248.5
Free Cash Flow
266.19169.8896.26102.59
Free Cash Flow Growth
56.70%76.48%-6.17%308.62%
Free Cash Flow Margin
41.81%33.39%25.94%33.59%
Free Cash Flow Per Share
3.302.341.581.69
Cash Income Tax Paid
72.4542.1819.7317.57
Levered Free Cash Flow
159.6579.6956.7368.87
Unlevered Free Cash Flow
159.6579.6956.7368.87
Change in Working Capital
32.83-6.155.963.07
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.